This bias may contribute to immune escape of tumors because T-cell-mediated tumor rejection requires a Th1-driven response involving IFN-γ and IL-12 rather than a Th2-prone milieu, which is promoted by IL-10 [14, 15, 26, 27]. This evidence concerns the gene IL10 and neoplasm.